Ibrahim Aldoss

8.0k total citations
190 papers, 2.5k citations indexed

About

Ibrahim Aldoss is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Ibrahim Aldoss has authored 190 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 101 papers in Public Health, Environmental and Occupational Health and 64 papers in Oncology. Recurrent topics in Ibrahim Aldoss's work include Acute Lymphoblastic Leukemia research (98 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Ibrahim Aldoss is often cited by papers focused on Acute Lymphoblastic Leukemia research (98 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (40 papers). Ibrahim Aldoss collaborates with scholars based in United States, Brazil and Italy. Ibrahim Aldoss's co-authors include Vinod Pullarkat, Stephen J. Forman, Anthony S. Stein, Guido Marcucci, Dan Douer, Ryotaro Nakamura, Joo Y. Song, Apar Kishor Ganti, Joycelynne Palmer and Tsewang Tashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ibrahim Aldoss

172 papers receiving 2.5k citations

Peers

Countries citing papers authored by Ibrahim Aldoss

Since Specialization

Citations

This map shows the geographic impact of Ibrahim Aldoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Aldoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Aldoss more than expected).

Fields of papers citing papers by Ibrahim Aldoss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Aldoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Aldoss. The network helps show where Ibrahim Aldoss may publish in the future.

Co-authorship network of co-authors of Ibrahim Aldoss

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Aldoss. A scholar is included among the top collaborators of Ibrahim Aldoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Aldoss. Ibrahim Aldoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure 2025 ·Blood Advances ·Kuo‐Kai Chin, Brian Ball, Yasmin Abaza, Jessica K. Altman, (unknown), Moiez Ali, Andriy Derkach, Mark B. Geyer, Aaron D. Goldberg, (unknown), Meghan C. Thompson, Jae H. Park, Martin S. Tallman, Sheng F. Cai, Eunice S. Wang, Ibrahim Aldoss, Eytan M. Stein	0
2	Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL) 2024 ·Transplantation and Cellular Therapy ·Armin Ghobadi, Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel, (unknown), Rawan Faramand, Ryan J. Mattison, Michael P. Rettig, Kenneth Jacobs, Ouiam Bakkacha, John Muth, (unknown), (unknown), (unknown), (unknown), Matthew Cooper, Jan Davidson‐Moncada, John F. DiPersio	1
3	Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Jeffrey Y.C. Wong, (unknown), Amandeep Salhotra, Savita Dandapani, Yan Wang, Joycelynne Palmer, Chunhui Han, (unknown), Eric H. Radany, Ibrahim Aldoss, Haris Ali, Leonardo Farol, Firoozeh Sahebi, Ricardo Spielberger, Gemma Marcucci, Ryotaro Nakamura, Eileen Smith, Susanta Hui, Stephen J. Forman, Anthony S. Stein	0
4	Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL) 2024 ·Annals of Hematology ·(unknown), Salman Otoukesh, (unknown), Guido Marcucci, Ibrahim Aldoss	0
5	Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer 2024 ·British Journal of Haematology ·(unknown), Jianying Zhang, (unknown), Vinod Pullarkat, Vaibhav Agrawal, Paul Koller, Monzr M. Al Malki, Ahmed Aribi, Amandeep Salhotra, Karamjeet Sandhu, Haris Ali, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ibrahim Aldoss	1
6	Positioning blinatumomab in the frontline of adult B-cell acute lymphoblastic leukemia treatment 2023 ·Frontiers in Oncology ·(unknown), Vaibhav Agrawal, Vinod Pullarkat, Ibrahim Aldoss	10
7	Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study 2023 ·Blood ·Ibrahim Aldoss, Josep‐María Ribera, Hagop M. Kantarjian, Pau Montesinos, Jessica Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, (unknown), Alexander Vorog, Bingxia Wang, Elias Jabbour	2
8	CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant 2023 ·Transplantation and Cellular Therapy ·Corinna La Rosa, Ibrahim Aldoss, (unknown), Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, (unknown), Shukaib Arslan, Andrew Artz, Brian Ball, Liana Nikolaenko, Vinod Pullarkat, Ryotaro Nakamura, Don J. Diamond	1
9	Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells 2022 ·Transplantation and Cellular Therapy ·Ibrahim Aldoss, Samer K. Khaled, M. Suzette Blanchard, Xiuli Wang, Jamie R. Wagner, Mary Ann Clark, Jennifer Simpson, Jinny Paul, Anthony S. Stein, Vinod Pullarkat, Amandeep Salhotra, Monzr M. Al Malki, Sandra P. Thomas, Lihua E. Budde, Guido Marcucci, Christine E. Brown, Stephen J. Forman	1
10	Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity 2022 ·Blood Advances ·(unknown), Corinna La Rosa, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, (unknown), Qiao Zhou, (unknown), (unknown), Teodora Kaltcheva, Daisy Johnson, (unknown), John A. Zaia, Ryotaro Nakamura, Monzr M. Al Malki, Don J. Diamond, Sanjeet Dadwal, Stephen J. Forman	3
11	Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide 2022 ·Blood Advances ·Monzr M. Al Malki, Joycelynne Palmer, Ni‐Chun Tsai, Sally Mokhtari, Susanta Hui, Weimin Tsai, Ibrahim Aldoss, Haris Ali, Ahmed Aribi, Thai M. Cao, Matthew Mei, Karamjeet Sandhu, Tanya Siddiqi, Stephen J. Forman, Ryotaro Nakamura, Guido Marcucci, Anthony S. Stein, Jeffrey Y.C. Wong, Joseph Rosenthal	15
12	Immunophenotype of acute lymphoblastic leukemia in minorities‐ analysis from the SEER database 2021 ·Hematological Oncology ·(unknown), (unknown), Rebecca A. Nelson, Ibrahim Aldoss, Vinod Pullarkat, Eduardo Magalhães Rego, Guido Marcucci, Dan Douer	3
13	A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia 2021 ·Cancer ·Gautam Borthakur, Olatoyosi Odenike, Ibrahim Aldoss, David A. Rizzieri, Thomas Prébet, Christopher S. Chen, Relja Popovic, Dimple Modi, (unknown), Johannes Wolff, Brian A. Jonas	51
14	Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant 2021 ·Blood Advances ·Monzr M. Al Malki, Ni‐Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai M. Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine M. Zain, Samer K. Khaled, Anthony S. Stein, David S. Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura	32
15	Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens 2021 ·Bone Marrow Transplantation ·Janny M. Yao, Dongyun Yang, Mary C. Clark, Salman Otoukesh, Thai M. Cao, Haris Ali, Shukaib Arslan, Ibrahim Aldoss, Andrew Artz, Idoroenyi Amanam, Amandeep Salhotra, Vinod Pullarkat, Karamjeet Sandhu, Anthony S. Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki	3
16	Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia 2020 ·American Journal of Hematology ·Ibrahim Aldoss, Jianying Zhang, Matthew Mei, Monzr M. Al Malki, Shukaib Arslan, Dat Ngo, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Amandeep Salhotra, Paul Koller, Samer K. Khaled, Andrew Artz, David S. Snyder, Ryotaro Nakamura, Stephen J. Forman, Anthony S. Stein, Guido Marcucci, Vinod Pullarkat	27
17	Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL 2020 ·Blood ·Yaqi Zhao, Ibrahim Aldoss, Chunxu Qu, Jeremy Chase Crawford, Zhaohui Gu, E. Kaitlynn Allen, Anthony E. Zamora, Thomas Alexander, Jeremy Wang, Hiroaki Goto, Toshihiko Imamura, Koshi Akahane, Guido Marcucci, Anthony S. Stein, Ravi Bhatia, Paul G. Thomas, Stephen J. Forman, Charles G. Mullighan, Kathryn G. Roberts	77
18	Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT) 2017 ·Blood ·Monzr M. Al Malki, Joo Y. Song, Dongyun Yang, Thai M. Cao, Ibrahim Aldoss, Sally Mokhtari, Sanjeet Dadwal, Ketevan Gendzekhadze, Anna Pawłowska, (unknown), Guido Marcucci, Chatchada Karanes, Pablo Parker, David S. Snyder, David Senitzer, Auayporn Nademanee, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat	2
19	High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes 2017 ·Blood ·Monzr M. Al Malki, Sanjeet Dadwal, Dongyun Yang, Sally Mokhtari, Thai M. Cao, Ketevan Gendzekhadze, Ibrahim Aldoss, Pablo Parker, Margaret O’Donnell, David S. Snyder, David Senitzer, Joseph Rosenthal, Auayporn Nademanee, Don J. Diamond, John A. Zaia, Stephen J. Forman, Ryotaro Nakamura	7
20	MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults 2016 ·Blood ·Corinna La Rosa, Jeff Longmate, Joy Martinez, Qiao Zhou, Teodora Kaltcheva, Weimin Tsai, (unknown), Mary Carroll, Felix Wussow, Flavia Chiuppesi, Nicola Hardwick, Sanjeet Dadwal, Ibrahim Aldoss, Ryotaro Nakamura, John A. Zaia, Don J. Diamond	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact